All HIV articles
-
NewsResearchers work toward universal flu, HIV vaccines
What if there was a way to achieve stronger, multi-year protection from a single flu jab? Researchers are looking to better understand a viral mechanism shared between influenza and HIV with the aim of disrupting infection. This research could help develop effective vaccines for both diseases, as well as new antivirals.
-
NewsTarget identified in treatment of neuroHIV
NeuroHIV occurs when HIV infection affects the function and structural integrity of the brain and, to some extent, the spinal cord and peripheral nervous system. New research has identified a brain protein driving this damage, pointing toward a possible treatment.
-
NewsLong-acting antibodies may work with the immune system to control HIV and help reduce the reservoir
Results from a clinical trial have offered a new HIV strategy, suggesting that just one or two doses of broadly neutralizing antibodies (bNAbs) can suppress the virus long-term, keeping it at undetectable levels for months and even years.
-
NewsThe Wistar Institute wins $15M+ NIH investment to advance HIV cure research strategies
The Wistar Institute has announced the National Institutes of Health (NIH) has awarded two major grants totaling more than $15M to Luis J. Montaner, D.V.M., D.Phil., director of Wistar’s HIV Cure and Viral Diseases Center.
-
NewsNew research offers avenue to explore relationship between Alzheimer’s and HIV
Researchers have created an animal model that helps resolve questions about the relationship between HIV and Alzheimer’s disease (AD). The virus that drives the root cause of AD initiates a complex chain that, with other disease partners, drives nerve cell injury and cognitive impairments for AD pathology.
-
NewsCancer medication helps reduce SIV reservoir, increases hope for HIV cure
Researchers have provided the first proof-of-concept in a nonhuman primate model for eliminating HIV-infected cells with venetoclax, a clinically approved medication for cancer.
-
NewsAnti-immigrant ‘public charge’ policy may have contributed to rise in HIV among Hispanic populations
Following the Trump administration’s 2018 announcement of changes to the public charge rule, antisanctuary counties in the US saw a 16.8% increase in HIV cases among Hispanic populations.
-
NewsPreventive TB treatment for individuals with HIV shown to be effective in real-world settings
A new study has evaluated the real-world impact of TB preventive treatment in six countries with high TB and HIV rates and highlights the importance of preventive treatment in reducing deaths caused by a curable disease.
-
NewsUC San Diego receives $12.3 million grant to study the intersection of HIV and methamphetamine use
A newly funded programme aims to use a multidisciplinary approach focused on improving the clinical care and brain health of people with HIV who also have an active methamphetamine use disorder.
-
NewsLong-acting therapies continue to gain momentum in HIV, says GlobalData
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.
-
NewsTriple-dose regimen may permanently clear HIV in infected newborns
New research suggests a one-time regimen of therapies given to newborns within three days of birth could permanently clear HIV infection.
-
NewsStudy finds HIV-1 proviruses may drive chronic systemic inflammation
People living with HIV are at higher risk of developing inflammatory diseases of many tissues, even when receiving antiviral treatments. A new study suggests that persistent hidden HIV contributes to this inflammation.
-
NewsTumor-like tissue environments could hold clues to curing HIV
The tissue microenvironments surrounding HIV-infected immune cells look a lot like those surrounding cancerous tumors, reports a new study. The findings help explain why HIV has been so difficult to cure.
-
NewsAdults living with HIV are at high risk for diabetes. Here’s why.
A new study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
-
NewsBioactive metabolite boosts HIV treatment response, reverses gut dysfunction
Scientists have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy in the nonhuman primate model of HIV/AIDS.
-
NewsAt-home, lab-quality HIV tests awarded $1.3 million for development
A new two-year, $1.3 million award will help researchers advance a proof-of-concept work toward commercialization of at-home HIV tests sensitive enough for early diagnosis comparable to—or exceeding—lab standards.
-
NewsResearchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk
New research has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.
-
NewsCascading disaster: While U.S. HIV infections have fallen, they are rising among Latinos
From 2010 to 2022, new HIV infections in the United States declined 19% overall but among Latinos, they rose 12%. In 2023, new HIV diagnoses among Latinos jumped 8% in a single year — the largest increase of any racial or ethnic group in the country.
-
NewsResearcher wins $5.6M NIH Avant Garde Award to prevent HIV, Hepatitis C and overdose
An innovative project will use AI-powered “digital twins” to help public health agencies better prevent HIV, hepatitis C and overdose among people who use drugs.
-
NewsWastewater analysis offers a new way to monitor HIV in communities
Human immunodeficiency virus 1 (HIV-1) detection in wastewater offers a novel approach to monitor the virus in communities. Hybrid-capture genetic sequencing allows researchers to analyze viral genomes in detail and specifically identify viral signals coming from community wastewater.